These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31448674)

  • 1. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
    Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
    Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of growth differentiation factor-15 restrains prostate cancer through regulating MAPK/ERK signaling pathway.
    Yang M; Guo M; Su C; Hao W; Xu Z
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):162-167. PubMed ID: 38650142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
    Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
    Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin.
    Xu J; Zhou J; Dai H; Liu F; Li W; Wang W; Guo F
    J Transl Med; 2018 Jun; 16(1):169. PubMed ID: 29921293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAE1 promotes gastric carcinogenesis and epithelial-mesenchymal transition.
    Dong W; Li X; Cheng L; Yang J; Zhao Z; Qiang X; Li P; Wu J; Guo L
    Arch Biochem Biophys; 2024 Apr; 754():109896. PubMed ID: 38417691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrin-releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer.
    Elshafae SM; Hassan BB; Supsavhad W; Dirksen WP; Camiener RY; Ding H; Tweedle MF; Rosol TJ
    Prostate; 2016 Jun; 76(9):796-809. PubMed ID: 26939805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Non-Coding RNA ZEB1-Antisense 1 Affects Cell Migration and Invasion of Cervical Cancer by Regulating Epithelial-Mesenchymal Transition via the p38MAPK Signaling Pathway.
    Gan L; Chen Y; Liu H; Ju WH
    Gynecol Obstet Invest; 2019; 84(2):136-144. PubMed ID: 30253398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Numb inhibits epithelial-mesenchymal transition via RBP-Jκ-dependent Notch1/PTEN/FAK signaling pathway in tongue cancer.
    Li JY; Huang WX; Zhou X; Chen J; Li Z
    BMC Cancer; 2019 Apr; 19(1):391. PubMed ID: 31023264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A switch from CD44⁺ cell to EMT cell drives the metastasis of prostate cancer.
    Shang Z; Cai Q; Zhang M; Zhu S; Ma Y; Sun L; Jiang N; Tian J; Niu X; Chen J; Sun Y; Niu Y
    Oncotarget; 2015 Jan; 6(2):1202-16. PubMed ID: 25483103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsa_circ_0051908 Promotes Hepatocellular Carcinoma Progression by Regulating the Epithelial-Mesenchymal Transition Process.
    Wu Y; Tang H; Cui S; Liao Q; Zeng L; Tu Y
    Anal Cell Pathol (Amst); 2024; 2024():8645534. PubMed ID: 38715919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Downregulation of SETDB1 suppresses epithelial mesenchymal transition and invasion and metastasis in oral cancer via SOX7 methylation].
    Hao Y; Bai XY; Huo F; Chen XB
    Shanghai Kou Qiang Yi Xue; 2024 Feb; 33(1):30-35. PubMed ID: 38583021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel role of LLGL2 silencing in autophagy: reversing epithelial-mesenchymal transition in prostate cancer.
    Hong GL; Kim KH; Kim YJ; Lee HJ; Cho SP; Han SY; Yang SW; Lee JS; Kang SK; Lim JS; Jung JY
    Biol Res; 2024 May; 57(1):25. PubMed ID: 38720397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/β-catenin signaling.
    Liu Y; Qin Z; Yang K; Liu R; Xu Y
    Oncol Rep; 2017 Mar; 37(3):1521-1528. PubMed ID: 28098905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer invasion is promoted by the miR-96-5p-induced NDRG1 deficiency through NF-κB regulation.
    Soror AA; Eshagh R; Fahim MR; Jamshidian A; Monfared GH
    Klin Onkol; 2024; 38(2):95-101. PubMed ID: 38697817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXS1 acts as an oncogene and induces EMT through FAK/PI3K/AKT pathway by upregulating HILPDA in prostate cancer.
    Ren R; Wang H; Xu Y; Wu J; Ma D; Guan W
    FASEB J; 2024 May; 38(10):e23698. PubMed ID: 38780613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer.
    Lv ZD; Yang ZC; Liu XP; Jin LY; Dong Q; Qu HL; Li FN; Kong B; Sun J; Zhao JJ; Wang HB
    J Cell Mol Med; 2016 Sep; 20(9):1640-50. PubMed ID: 27027510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the Twist gene on the invasion and metastasis of colon cancer.
    Wang D; Rai B; Qi F; Liu T; Wang J; Wang X; Ma B
    Oncol Rep; 2018 Jan; 39(1):31-44. PubMed ID: 29115546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semaphorin-5A maintains epithelial phenotype of malignant pancreatic cancer cells.
    Saxena S; Purohit A; Varney ML; Hayashi Y; Singh RK
    BMC Cancer; 2018 Dec; 18(1):1283. PubMed ID: 30577767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, invasion, and metastasis of pancreatic cancer cells.
    Gao Y; Hou J; Fei X; Ren L; Lu R; Liu P; Liu S; Zhu C; Wang X; Pan Y
    Cell Signal; 2024 Aug; 120():111227. PubMed ID: 38744388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HHLA2 deficiency inhibits pancreatic cancer progression and THP-1 macrophage M2 polarization via EGFR/MAPK/ERK and mTOR/AKT pathway.
    Zhou S; Wang Z; Zhao D; Fu Y; Zhang S; Wang Z; Zou X
    World J Surg Oncol; 2024 May; 22(1):133. PubMed ID: 38762741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.